Indian pharma companies may stand to gain market share due to the potential impact of US tariffs, according to a JPMorgan report.
News Today | First with the news
News Today | First with the news
Indian pharma companies may stand to gain market share due to the potential impact of US tariffs, according to a JPMorgan report.